COVID-19 Vaccination in the WHO African Region: Progress Made in 2022 and Factors Associated

This study summarizes progress made in rolling out COVID-19 vaccinations in the African region in 2022, and analyzes factors associated with vaccination coverage. Data on vaccine uptake reported to the World Health Organization (WHO) Regional Office for Africa by Member States between January 2021 and December 2022, as well as publicly available health and socio-economic data, were used. A negative binomial regression was performed to analyze factors associated with vaccination coverage in 2022. As of the end of 2022, 308.1 million people had completed the primary vaccination series, representing 26.4% of the region’s population, compared to 6.3% at the end of 2021. The percentage of health workers with complete primary series was 40.9%. Having carried out at least one high volume mass vaccination campaign in 2022 was associated with high vaccination coverage (β = 0.91, p < 0.0001), while higher WHO funding spent per person vaccinated in 2022 was correlated with lower vaccination coverage (β = −0.26, p < 0.03). All countries should expand efforts to integrate COVID-19 vaccinations into routine immunization and primary health care, and increase investment in vaccine demand generation during the transition period that follows the acute phase of the pandemic.

[1]  F. Ngalesoni,et al.  COVID-19 Vaccine Uptake and Associated Factors in Sub-Saharan Africa: Evidence from a Community-Based Survey in Tanzania , 2023, Vaccines.

[2]  O. Dyer Covid-19: Winter surge feared as China lurches away from zero covid , 2022, BMJ.

[3]  I. Boutron,et al.  Efficacy and safety of COVID‐19 vaccines , 2022, The Cochrane database of systematic reviews.

[4]  M. Sauer,et al.  Building and sustaining public and political commitment to the value of vaccination: Recommendations for the Immunization Agenda 2030 (Strategic Priority Area 2) , 2022, Vaccine.

[5]  C. Napoli,et al.  The Effect of Preventive Measures and Vaccination against SARS-CoV-2 on the Infection Risk, Treatment, and Hospitalization: A Cross-Sectional Study of Algeria , 2022, Viruses.

[6]  E. O. Njoga,et al.  Persisting Vaccine Hesitancy in Africa: The Whys, Global Public Health Consequences and Ways-Out—COVID-19 Vaccination Acceptance Rates as Case-in-Point , 2022, Vaccines.

[7]  H. Rees,et al.  COVID-19 vaccination rollout in the World Health Organization African region: status at end June 2022 and way forward , 2022, Epidemiology and Infection.

[8]  I. Morhason-Bello,et al.  Commentary on COVID-19 Vaccine Hesitancy in sub-Saharan Africa , 2022, Tropical medicine and infectious disease.

[9]  O. Watson,et al.  Global impact of the first year of COVID-19 vaccination: a mathematical modelling study , 2022, The Lancet Infectious Diseases.

[10]  A. Galvani,et al.  The global impact of disproportionate vaccination coverage on COVID-19 mortality , 2022, The Lancet Infectious Diseases.

[11]  T. Hirao,et al.  COVID-19 outbreak trends in South Africa: A comparison of Omicron (B.1.1.529), Delta (B.1.617.2), and Beta (B.1.351) variants outbreak periods , 2022, Journal of Infection and Public Health.

[12]  O. Olu-Abiodun,et al.  COVID-19 vaccination in Nigeria: A rapid review of vaccine acceptance rate and the associated factors , 2022, PloS one.

[13]  J. Lazarus,et al.  COVID-19 vaccine wastage in the midst of vaccine inequity: causes, types and practical steps , 2022, BMJ Global Health.

[14]  C. Willison,et al.  Resources or trust: What matters more in the vaccination strategies of high-income liberal democracies? , 2022, Health Policy and Technology.

[15]  Israel Oluwaseyidayo Idris,et al.  Why many African countries may not achieve the 2022 COVID-19 vaccination coverage target , 2022, Tropical Medicine and Health.

[16]  C. Tsagkaris,et al.  Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward , 2022, Human vaccines & immunotherapeutics.

[17]  E. Klein,et al.  A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads , 2022, medRxiv.

[18]  Our world in data , 2022 .

[19]  A. Jatau,et al.  Low rate of COVID-19 vaccination in Africa: a cause for concern , 2022, Therapeutic advances in vaccines and immunotherapy.

[20]  F. Paolucci,et al.  An analysis of the COVID-19 vaccination campaigns in France, Israel, Italy and Spain and their impact on health and economic outcomes , 2021, Health Policy and Technology.

[21]  A. Galvani,et al.  Importance of non-pharmaceutical interventions in the COVID-19 vaccination era: A case study of the Seychelles , 2021, Journal of global health.

[22]  A. Kaminga,et al.  Seroprevalence of anti‐SARS‐CoV‐2 antibodies in Africa: A systematic review and meta‐analysis , 2021, Reviews in medical virology.

[23]  S. D. De Smedt,et al.  The dawn of mRNA vaccines: The COVID-19 case , 2021, Journal of Controlled Release.

[24]  M. Makoni Tanzania refuses COVID-19 vaccines , 2021, The Lancet.

[25]  A. Israeli,et al.  Israel’s rapid rollout of vaccinations for COVID-19 , 2021, Israel Journal of Health Policy Research.

[26]  WHO ISSUES ITS FIRST EMERGENCY USE VALIDATION FOR A COVID-19 VACCINE AND EMPHASIZES NEED FOR EQUITABLE GLOBAL ACCESS , 2021, Saudi Medical Journal.

[27]  顏素美 Suh-May Yen,et al.  The American Journal of Managed Care , 2015 .

[28]  Rebecca Katz,et al.  IDSR as a platform for implementing IHR in African countries. , 2013, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[29]  Zoran Bursac,et al.  Purposeful selection of variables in logistic regression , 2008, Source Code for Biology and Medicine.

[30]  C. Pipper,et al.  [''R"--project for statistical computing]. , 2008, Ugeskrift for laeger.

[31]  M. Autelitano [International health regulation]. , 1991, Annali di igiene : medicina preventiva e di comunita.

[32]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[33]  J. Grabenstein,et al.  Mass immunization programs: principles and standards. , 2006, Current topics in microbiology and immunology.